Click here to get full coverage on How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - news.stocktradersdaily.com

How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing  news.stocktradersdaily.com

How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) Earnings Transcript - The Motley Fool

Pulse Biosciences (PLSE) Earnings Transcript  The Motley Fool

Pulse Biosciences (PLSE) Earnings Transcript - The Motley Fool

Click here to get full coverage on Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline - Sahm

Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline  Sahm

Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline - Sahm

Click here to get full coverage on Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval - Quiver Quantitative

Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval  Quiver Quantitative

Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval - Quiver Quantitative

Click here to get full coverage on Pulse Biosciences (PLSE): Assessing Valuation Following Modest Share Rebound and Recent Slowdown - simplywall.st

Pulse Biosciences (PLSE): Assessing Valuation Following Modest Share Rebound and Recent Slowdown  simplywall.st

Pulse Biosciences (PLSE): Assessing Valuation Following Modest Share Rebound and Recent Slowdown - simplywall.st

Click here to get full coverage on Pulse Biosciences (PLSE) CTO Uecker sells $731,200 in shares - Investing.com

Pulse Biosciences (PLSE) CTO Uecker sells $731,200 in shares  Investing.com

Pulse Biosciences (PLSE) CTO Uecker sells $731,200 in shares - Investing.com

Click here to get full coverage on Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed?  Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Did Widening Losses and NANOCLAMP AF Study Shift Pulse Biosciences' (PLSE) Investment Narrative? - Sahm

Did Widening Losses and NANOCLAMP AF Study Shift Pulse Biosciences' (PLSE) Investment Narrative?  Sahm

Did Widening Losses and NANOCLAMP AF Study Shift Pulse Biosciences' (PLSE) Investment Narrative? - Sahm

Click here to get full coverage on PULSE BIOSCIENCES Earnings Results: $PLSE Reports Quarterly Earnings | PLSE Stock News - Quiver Quantitative

PULSE BIOSCIENCES Earnings Results: $PLSE Reports Quarterly Earnings | PLSE Stock News  Quiver Quantitative

PULSE BIOSCIENCES Earnings Results: $PLSE Reports Quarterly Earnings | PLSE Stock News - Quiver Quantitative

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial  Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE): Valuation in Focus After First NANOCLAMP AF Study Procedure Completion - Yahoo Finance

Pulse Biosciences (PLSE): Valuation in Focus After First NANOCLAMP AF Study Procedure Completion  Yahoo Finance

Pulse Biosciences (PLSE): Valuation in Focus After First NANOCLAMP AF Study Procedure Completion - Yahoo Finance

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline - simplywall.st

Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline  simplywall.st

Pulse Biosciences (PLSE): Evaluating Valuation After Recent Share Price Decline - simplywall.st

Click here to get full coverage on Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Pulse Biosciences is Now Oversold (PLSE) - Nasdaq

Pulse Biosciences is Now Oversold (PLSE)  Nasdaq

Pulse Biosciences is Now Oversold (PLSE) - Nasdaq

Click here to get full coverage on Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2025 Earnings Call Transcript - Insider Monkey

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2025 Earnings Call Transcript  Insider Monkey

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million - Investing.com

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million  Investing.com

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million - Investing.com

Click here to get full coverage on $PLSE stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$PLSE stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$PLSE stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results - Business Wire

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results  Business Wire

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results - Business Wire

Click here to get full coverage on PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment - Nasdaq

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment  Nasdaq

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment - Nasdaq

Click here to get full coverage on How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study  Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

Click here to get full coverage on Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛

Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22  富途牛牛

Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛

Click here to get full coverage on Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership  Yahoo Finance

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance

Click here to get full coverage on Insider Sale: Chief Commercial Officer of $PLSE Sells 20,000 Shares - Quiver Quantitative

Insider Sale: Chief Commercial Officer of $PLSE Sells 20,000 Shares  Quiver Quantitative

Insider Sale: Chief Commercial Officer of $PLSE Sells 20,000 Shares - Quiver Quantitative

Click here to get full coverage on PLSE to Participate in Oppenheimer Virtual Event This November - GuruFocus

PLSE to Participate in Oppenheimer Virtual Event This November  GuruFocus

PLSE to Participate in Oppenheimer Virtual Event This November - GuruFocus

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on Medical Tech Company Pulse Biosciences Issues Strategic Equity Grants for Nanosecond PFA Innovation - Stock Titan

Medical Tech Company Pulse Biosciences Issues Strategic Equity Grants for Nanosecond PFA Innovation  Stock Titan

Medical Tech Company Pulse Biosciences Issues Strategic Equity Grants for Nanosecond PFA Innovation - Stock Titan

Click here to get full coverage on Pardon Me: Exploring the Harms of Criminal Records and Benefits of Executive Pardons - ACLU of Pennsylvania

Pardon Me: Exploring the Harms of Criminal Records and Benefits of Executive Pardons  ACLU of Pennsylvania

Pardon Me: Exploring the Harms of Criminal Records and Benefits of Executive Pardons - ACLU of Pennsylvania

Click here to get full coverage on Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 - Business Wire

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025  Business Wire

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 - Business Wire

Click here to get full coverage on Here's Why We're Not At All Concerned With Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Situation - simplywall.st

Here's Why We're Not At All Concerned With Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Situation  simplywall.st

Here's Why We're Not At All Concerned With Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Situation - simplywall.st

Click here to get full coverage on Pulse Biosciences, Inc. Updates Investor Presentation - TradingView

Pulse Biosciences, Inc. Updates Investor Presentation  TradingView

Pulse Biosciences, Inc. Updates Investor Presentation - TradingView

Click here to get full coverage on Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q3 Revenue $86,000 - MarketScreener

Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q3 Revenue $86,000  MarketScreener

Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q3 Revenue $86,000 - MarketScreener

Click here to get full coverage on Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study - Business Wire

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study  Business Wire

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study - Business Wire

Click here to get full coverage on Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha

Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE)  Seeking Alpha

Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha

Click here to get full coverage on Pulse Biosciences Unveils Promising First-in-Human Data for nPulse - Zacks Investment Research

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse  Zacks Investment Research

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse - Zacks Investment Research

Click here to get full coverage on Pulse Biosciences shares strong first-in-human PFA data - MassDevice

Pulse Biosciences shares strong first-in-human PFA data  MassDevice

Pulse Biosciences shares strong first-in-human PFA data - MassDevice

Click here to get full coverage on Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - Investing News Network

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences  Investing News Network

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - Investing News Network

Click here to get full coverage on Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha

Pulse Biosciences: Some Key Questions Remain Unanswered  Seeking Alpha

Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha

Click here to get full coverage on Pulse Biosciences Inc (PLSE) reports earnings - qz.com

Pulse Biosciences Inc (PLSE) reports earnings  qz.com

Pulse Biosciences Inc (PLSE) reports earnings - qz.com

Click here to get full coverage on Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - Business Wire

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results  Business Wire

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - Business Wire

Click here to get full coverage on Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com

Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential  Investing.com

Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com

Click here to get full coverage on Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study - Nasdaq

Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study  Nasdaq

Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study - Nasdaq

Click here to get full coverage on Pulse Biosciences Launches NANOCLAMP AF Clinical Trial - TipRanks

Pulse Biosciences Launches NANOCLAMP AF Clinical Trial  TipRanks

Pulse Biosciences Launches NANOCLAMP AF Clinical Trial - TipRanks

Click here to get full coverage on Pulse Biosciences CCO Danahy sells $377k in shares - Investing.com

Pulse Biosciences CCO Danahy sells $377k in shares  Investing.com

Pulse Biosciences CCO Danahy sells $377k in shares - Investing.com

Click here to get full coverage on Will PLSE stock deliver better than expected guidance - July 2025 Levels & Real-Time Market Trend Scan - Fundação Cultural do Pará

Will PLSE stock deliver better than expected guidance - July 2025 Levels & Real-Time Market Trend Scan  Fundação Cultural do Pará

Will PLSE stock deliver better than expected guidance - July 2025 Levels & Real-Time Market Trend Scan - Fundação Cultural do Pará

Click here to get full coverage on Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22 - 富途牛牛

Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22  富途牛牛

Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22 - 富途牛牛

Click here to get full coverage on Earnings Preview: PLSE to Report Financial Results Post-market on August 12 - 富途牛牛

Earnings Preview: PLSE to Report Financial Results Post-market on August 12  富途牛牛

Earnings Preview: PLSE to Report Financial Results Post-market on August 12 - 富途牛牛

Click here to get full coverage on Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million By Investing.com - Investing.com Nigeria

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million By Investing.com  Investing.com Nigeria

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million By Investing.com - Investing.com Nigeria

Click here to get full coverage on Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid - Business Wire

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid  Business Wire

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid - Business Wire

Click here to get full coverage on Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Business Wire

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting  Business Wire

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Business Wire

Click here to get full coverage on Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com

Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up  Investing.com

Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com

Click here to get full coverage on Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference - Business Wire

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference  Business Wire

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference - Business Wire

Click here to get full coverage on When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - Stock Titan

When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader  Stock Titan

When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - Stock Titan

Click here to get full coverage on Pulse Biosciences enrolls first patient in NANOCLAMP PFA trial - MassDevice

Pulse Biosciences enrolls first patient in NANOCLAMP PFA trial  MassDevice

Pulse Biosciences enrolls first patient in NANOCLAMP PFA trial - MassDevice

Click here to get full coverage on Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop - Yahoo Finance

Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop  Yahoo Finance

Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop - Yahoo Finance

Click here to get full coverage on Pulse Biosciences CCO Danahy sells $85k in shares - Investing.com

Pulse Biosciences CCO Danahy sells $85k in shares  Investing.com

Pulse Biosciences CCO Danahy sells $85k in shares - Investing.com

Click here to get full coverage on Pulse Biosciences Reveals Promising Study Results - TipRanks

Pulse Biosciences Reveals Promising Study Results  TipRanks

Pulse Biosciences Reveals Promising Study Results - TipRanks

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Pulse Biosciences picks former Boston Scientific exec as new CEO - MassDevice

Pulse Biosciences picks former Boston Scientific exec as new CEO  MassDevice

Pulse Biosciences picks former Boston Scientific exec as new CEO - MassDevice

Click here to get full coverage on My First Look at the New 2025 TradingView Stock Screener for NASDAQ:PLSE by zAngus - TradingView

My First Look at the New 2025 TradingView Stock Screener for NASDAQ:PLSE by zAngus  TradingView

My First Look at the New 2025 TradingView Stock Screener for NASDAQ:PLSE by zAngus - TradingView

Click here to get full coverage on Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants - Business Wire

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants  Business Wire

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants - Business Wire

Click here to get full coverage on Pulse Biosciences has a new CFO - MassDevice

Pulse Biosciences has a new CFO  MassDevice

Pulse Biosciences has a new CFO - MassDevice

Click here to get full coverage on Meet Mike Lee, ACLU-PA’s new executive director - ACLU of Pennsylvania

Meet Mike Lee, ACLU-PA’s new executive director  ACLU of Pennsylvania

Meet Mike Lee, ACLU-PA’s new executive director - ACLU of Pennsylvania

Click here to get full coverage on Costs and Fees Charged To Indigent Criminal Defendants in Philadelphia County - Fines and Fees Justice Center

Costs and Fees Charged To Indigent Criminal Defendants in Philadelphia County  Fines and Fees Justice Center

Costs and Fees Charged To Indigent Criminal Defendants in Philadelphia County - Fines and Fees Justice Center

Click here to get full coverage on PTA takes steps to improve telecom connectivity - The Express Tribune

PTA takes steps to improve telecom connectivity  The Express Tribune

PLSE

Price Chart

Key Statistics

Technicals

About PLSE

Latest News

How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Pulse Biosciences (PLSE) Earnings Transcript - The Motley Fool

Advanced Charts

Top Gainers

Top Losers